Age-stratified distribution of metastatic sites in bladder cancer: A population-based analysis

被引:45
作者
Bianchi, Marco [1 ,2 ]
Roghmann, Florian [1 ,5 ]
Becker, Andreas [1 ,6 ]
Sukumar, Shyam [4 ]
Briganti, Alberto [7 ]
Menon, Mani [4 ]
Karakiewicz, Pierre I. [1 ,3 ]
Sun, Maxine [1 ]
Noldus, Joachim [5 ]
Quoc-Dien Trinh [4 ]
机构
[1] Univ Montreal, Ctr Hlth, Canc Prognost & Hlth Outcomes Unit, Montreal, PQ, Canada
[2] Univ Vita Salute San Raffaele, Dept Urol, Milan, Italy
[3] Univ Montreal, Ctr Hlth, Dept Urol, Montreal, PQ, Canada
[4] Henry Ford Hlth Syst, Vattikuti Urol Inst, Detroit, MI USA
[5] Ruhr Univ Bochum, Dept Urol, Marienhosp, Herne, Germany
[6] Prostate Canc Ctr, Martini Clin, Hamburg, Germany
[7] Univ Vita Salute San Raffaele, Urol Res Inst, Dept Urol, Milan, Italy
来源
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL | 2014年 / 8卷 / 3-4期
关键词
RENAL-CELL CARCINOMA; UROTHELIAL CARCINOMA; PRIMARY TUMOR; SURVIVAL; PATTERN; ADULTS;
D O I
10.5489/cuaj.787
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Urothelial carcinoma of the urinary bladder (UCUB) is the most common malignancy of the urinary tract. We examined the distribution of site-specific metastases in patients with UCUB according to age and we assessed contemporary recommendations proposed by guidelines with regard to distant metastases. Methods: Patients with metastatic UCUB (mUCUB) were abstracted from the Nationwide Inpatient Sample (1998-2007). Age was stratified into quartiles: < 63, 64-72, 73-79 and >= 80 years. Cochran-Armitage trend test and multivariable logistic regression analysis tested the relationship between age and the rate of metastases. Finally, we identified patients at high risk of brain or bone metastases. Results: Within 7543 patients with mUCUB, 25%, 24%, 23%, 19%, 18% and 3% had lymph node, bone, urinary, lung and liver metastases, respectively. Overall, the rate of concomitant metastases was 29%. The rate of multiple metastatic sites decreased with increasing age (p < 0.001). This was confirmed in patients with lung, bone, liver, urinary system and brain metastases (all p <= 0.04). The rate of bone metastases was 15.0% in patients with exclusive abdominal metastases and 40.0% in patients with abdominal, thoracic and brain metastases. The rate of brain metastases was 1% in patients with exclusive abdominal metastases and 7% in patients with thoracic and bone metastases. Our findings are limited by the retrospective nature of the analyses. Conclusions: We report a higher number of concomitant metastatic sites in young UCUB patients. Bone metastases are frequent in all patient groups, whereas brain metastases are common in UCUB patients with thoracic and/or bone metastases.
引用
收藏
页码:E148 / E158
页数:11
相关论文
共 23 条
[1]   Xp11 translocation renal cell carcinoma in adults: Expanded clinical, pathologic, and genetic spectrum [J].
Argani, Pedram ;
Olgac, Semra ;
Tickoo, Satish K. ;
Goldfischer, Michael ;
Moch, Holger ;
Chan, David Y. ;
Eble, John N. ;
Bonsib, Stephen M. ;
Jimeno, Mireya ;
Lloreta, Josep ;
Billis, Athanase ;
Hicks, Jessica ;
De Marzo, Angelo M. ;
Reuter, Victor E. ;
Ladanyi, Marc .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (08) :1149-1160
[2]   Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy [J].
Bajorin, DF ;
Dodd, PM ;
Mazumdar, M ;
Fazzari, M ;
McCaffrey, JA ;
Scher, HI ;
Herr, H ;
Higgins, G ;
Boyle, MG .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (10) :3173-3181
[3]   Patient and Tumor Characteristics Associated With Increased Mortality in Young Women (≤40 Years) With Breast Cancer [J].
Bharat, Ankit ;
Aft, Rebecca L. ;
Gao, Feng ;
Margenthaler, Julie A. .
JOURNAL OF SURGICAL ONCOLOGY, 2009, 100 (03) :248-251
[4]   Distribution of metastatic sites in renal cell carcinoma: a population-based analysis [J].
Bianchi, M. ;
Sun, M. ;
Jeldres, C. ;
Shariat, S. F. ;
Trinh, Q. -D. ;
Briganti, A. ;
Tian, Z. ;
Schmitges, J. ;
Graefen, M. ;
Perrotte, P. ;
Menon, M. ;
Montorsi, F. ;
Karakiewicz, P. I. .
ANNALS OF ONCOLOGY, 2012, 23 (04) :973-980
[5]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[6]   Bladder Cancer [J].
Clark, Peter E. ;
Agarwal, Neeraj ;
Biagio, Matthew C. ;
Eisenberger, Mario A. ;
Greenberg, Richard E. ;
Herr, Harry W. ;
Inman, Brant A. ;
Kuban, Deborah A. ;
Kuzel, Timothy M. ;
Lele, Subodh M. ;
Michalski, Jeff ;
Pagliaro, Lance C. ;
Pal, Sumanta K. ;
Patterson, Anthony ;
Plimack, Elizabeth R. ;
Pohar, Kamal S. ;
Porter, Michael P. ;
Richie, Jerome P. ;
Sexton, Wade J. ;
Shipley, William U. ;
Small, Eric J. ;
Spiess, Philippe E. ;
Trump, Donald L. ;
Wile, Geoffrey ;
Wilson, Timothy G. ;
Dwyer, Mary ;
Ho, Maria .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (04) :446-475
[7]  
Derwinger K, 2010, ANTICANCER RES, V30, P5227
[8]   ADAPTING A CLINICAL COMORBIDITY INDEX FOR USE WITH ICD-9-CM ADMINISTRATIVE DATABASES [J].
DEYO, RA ;
CHERKIN, DC ;
CIOL, MA .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (06) :613-619
[9]   ICUD-EAU International Consultation on Bladder Cancer 2012: Radical Cystectomy and Bladder Preservation for Muscle-Invasive Urothelial Carcinoma of the Bladder [J].
Gakis, Georgios ;
Efstathiou, Jason ;
Lerner, Seth P. ;
Cookson, Michael S. ;
Keegan, Kirk A. ;
Guru, Khurshid A. ;
Shipley, William U. ;
Heidenreich, Axel ;
Schoenberg, Mark P. ;
Sagaloswky, Arthur I. ;
Soloway, Mark S. ;
Stenzl, Arnulf .
EUROPEAN UROLOGY, 2013, 63 (01) :45-57
[10]  
Healthcare Cost and Utilization Project (H-CUP), 2008, QUAL CONTR PROC, P29